| Jump to: | Authorized Access | | | Attribution | | | Authorized Requests |
- Study Description
-
Important Links and Information
-
Request access via Authorized Access
- Instructions for requestors
- Data Use Certification (DUC) Agreement
- Talking Glossary of Genetic Terms
Two patient-derived organoids were derived from separate ascites fluid collections from a patient diagnosed with high-grade mullerian carcinoma, that could not be confidently subclassified based on the limited specimen. Long-read sequencing whole genome sequencing (WGS) was performed on the organoids, OC104 and OC109, using the Oxford Nanopore Technologies PromethION24 with V14 ligation kit. Information from genomic findings and further pathology on organoids suggests refining the diagnosis to mucinous ovarian carcinoma.
- Study Design:
- Case Set
- Study Type:
- Case Set
- Sequencing
- Total number of consented subjects: 1
- Subject Sample Telemetry Report (SSTR)
-
Request access via Authorized Access
- Authorized Access
- Publicly Available Data
- Link to other NCBI resources related to this study
- Selected Publications
- Diseases/Traits Related to Study (MeSH terms)
-
- Primary Phenotype: Ovarian Neoplasms
- Authorized Data Access Requests
- Study Attribution
-
-
Principal Investigator
- Jessica D. Lang. University of Wisconsin-Madison, Madison, WI, USA.
-
Principal Investigator